Although influenza is primarily considered a respiratory infection and causes significant
respiratory mortality, evidence suggests that influenza has an additional burden due to …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

European guidelines on cardiovascular prevention in clinical practice were first published in
1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

Background COVID-19 is a complex disease targeting many organs. Previous studies
highlight COVID-19 as a probable risk factor for acute cardiovascular complications. We …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

Background Long-term effects of COVID-19, also called Long COVID, affect more than 10%
of patients. The most severe cases (ie those requiring hospitalization) present a higher …

Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are
common, associated with acute inflammation, and may increase subsequent cardiovascular …

Influenza infection increases the incidence of myocardial infarction but the reason is
unknown. Platelets mediate vascular occlusion through thrombotic functions but are also …

Cardiovascular disease (CVD) follows a seasonal pattern in many populations. Broadly
defined winter peaks and clusters of all subtypes of CVD after'cold snaps' are consistently …

Despite widespread influenza vaccination programs, influenza remains a major cause of
morbidity and mortality in older adults. Age-related changes in multiple aspects of the …